All In Biotech

Drug Trial Radar · NCT03074435

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire: Research on Vector Control Strategies

Last checked: Nov 19, 2026Latest source record: Oct 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 15,776 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

15,776

Actual

Start

Jul 2016

Primary completion

Aug 2018

Study completion Aug 2018

Sponsor

Lead sponsor
Institut de Recherche pour le DeveloppementGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
Institut de Recherche en Sciences de la Sante, Burkina Faso; Institut Pierre Richet
First posted
Mar 8, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, up to 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study evaluates the benefit to use 1) insecticide residual sprayings, 2) larvicides, 3) Ivermectin for domestic animals and 4) behaviour change communication strategy to complement the universal coverage with LLINs through a cluster randomized trial.

Conditions

  • Malaria

Interventions

  • Indoor residual sprayingsDevice

    Houses will be spayed with this formulation containing Pyrimiphos methyl.

  • LarvicideDevice

    Larval breeding sites will be treated with larvicide

  • BCCBehavioral

  • IvermectinBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Malaria incidence densityTime frame: continuous monitoring during 2 years

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Institut de Recherche en Sciences de la Santé

    Bobo-Dioulasso, Burkina Faso

  • Institut Pierre Richet

    Bouaké, Côte d’Ivoire

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.